New hope for transplant patients battling dangerous immune reaction
Disease control
Not yet recruiting
This study is testing whether adding an experimental drug called Gecacitinib to standard steroid treatment can better control acute Graft-Versus-Host Disease (aGVHD) in adults who recently received a stem cell transplant. The trial will enroll 25 patients with moderate to severe …
Phase: PHASE2 • Sponsor: Bin Gu • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC